• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Flint D. Besecker joins Kinex as chief financial officer

Flint D. Besecker joins Kinex as chief financial officer

July 16, 2013
CenterWatch Staff

Kinex Pharmaceuticals, a specialty biotech focused on the development and commercialization of next generation oral therapies for cancer diseases, has appointed Flint D. Besecker to its executive team as chief financial officer and executive vice president. Besecker will have primary responsibility over all non-scientific aspects of Kinex, reporting to Kinex's chief executive officer, Dr. Johnson Lau. Flint has been an investor and board director of Kinex since 2011.

"Flint has experience in capital markets and strategy having worked for GE Healthcare Financial Services and as founder and president of CIT Healthcare; both fortune 500 companies. He also has experience in a public company environment having led Care Investment Trust's initial public offering and listing on the New York Stock Exchange," Lau said.

Besecker has 20 years of experience in the healthcare industry. He currently runs Firestone Asset Management, a private investment and advisory firm in the healthcare industry. He also is vice chairman of Ameris Acquisitions, a private Nashville hospital company. His previous roles included chief executive officer of the Center for Hospice and Palliative Care, founder of Care Investment Trust, founder of CIT Healthcare, managing director of GE Healthcare Financial Services and chief risk officer of Heller Healthcare.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing